Evaluation of AgNORs in Oral Potentially Malignant Lesions

Figure 2

(a), (b), and (c): epithelial lining of inflammatory fibrous hyperplasia; (d), (e), and (f): low risk of malignancy epithelial dysplasia; (g), (h), and (i): high risk of malignancy epithelial dysplasia; (j), (k), and (l): squamous cell carcinoma. (a), (d), (g), and (j): H&E, 100x; (b), (e), (h), and (k): AgNOR, 100x; (c), (f), (i), and (l): AgNOR, 400x.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)